 Remission Induction
"Remission Induction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapeutic act or process that initiates a response to a complete or partial remission level.
| Descriptor ID |
D012074
|
| MeSH Number(s) |
E02.860
|
| Concept/Terms |
Remission Induction- Remission Induction
- Induction, Remission
- Inductions, Remission
- Induction of Remission
- Remission Inductions
|
Below are MeSH descriptors whose meaning is more general than "Remission Induction".
Below are MeSH descriptors whose meaning is more specific than "Remission Induction".
This graph shows the total number of publications written about "Remission Induction" by people in this website by year, and whether "Remission Induction" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 8 | 8 | | 1996 | 0 | 1 | 1 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 2 | 2 | | 1999 | 0 | 2 | 2 | | 2000 | 0 | 3 | 3 | | 2001 | 0 | 6 | 6 | | 2002 | 0 | 2 | 2 | | 2003 | 0 | 2 | 2 | | 2004 | 1 | 5 | 6 | | 2005 | 0 | 2 | 2 | | 2006 | 0 | 1 | 1 | | 2007 | 0 | 3 | 3 | | 2008 | 0 | 6 | 6 | | 2009 | 0 | 8 | 8 | | 2010 | 0 | 8 | 8 | | 2011 | 0 | 7 | 7 | | 2012 | 2 | 10 | 12 | | 2013 | 0 | 11 | 11 | | 2014 | 0 | 11 | 11 | | 2015 | 0 | 9 | 9 | | 2016 | 0 | 8 | 8 | | 2017 | 0 | 9 | 9 | | 2018 | 0 | 16 | 16 | | 2019 | 2 | 16 | 18 | | 2020 | 0 | 13 | 13 | | 2021 | 0 | 7 | 7 | | 2022 | 0 | 4 | 4 | | 2023 | 0 | 8 | 8 | | 2024 | 5 | 10 | 15 | | 2025 | 0 | 9 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Remission Induction" by people in Profiles.
-
Hamada Y, Thomas D, McDonald VM, Harvey ES, Fricker M, Gillman A, Hew M, Kritikos V, Upham JW, Gibson PG. Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab. Ann Allergy Asthma Immunol. 2025 Nov; 135(5):537-546.e12.
-
Louis R, Lommatzsch M, Jackson DJ, Menzies-Gow A, Shavit A, Cohen D, Hoyte FCL, Korn S. Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction. Clin Exp Allergy. 2025 Jul; 55(7):521-531.
-
Thomas D, Lewthwaite H, Gibson PG, Majellano E, Clark V, Fricker M, Hamada Y, Anderson GP, Backer V, Bardin P, Beasley R, Chien J, Farah CS, Harrington J, Harvey E, Hew M, Holland AE, Jenkins C, Katelaris CH, Katsoulotos G, Murray K, Peters M, Thomas R, Tonga K, Upham JW, Wark P, McDonald VM. Unlocking Asthma Remission: Key Insights From an Expert Roundtable Discussion. Respirology. 2025 Jun; 30(6):466-479.
-
Eggert L, Rhoads S, Wechsler ME, Akuthota P. Con: clinical remission in asthma - not yet there. Eur Respir Rev. 2025 Apr; 34(176).
-
Singh S, Nguyen JD, Fudman DI, Gerich ME, Shah SA, Hudesman D, McConnell RA, Lukin DJ, Flynn AD, Hwang C, Sprung B, Gaidos JKJ, Mattar MC, Rubin DT, Hashash JG, Metwally M, Ali T, Ma C, Hoentjen F, Narula N, Bessissow T, Rosenfeld G, McCurdy JD, Ananthakrishnan AN, Cross RK, Rodriguez Gaytan JR, Gurrola ES, Patel S, Siegel CA, Melmed GY, Weaver SA, Power S, Zou G, Jairath V, Hou JK. Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial. BMJ Open Gastroenterol. 2025 Mar 31; 12(1).
-
Malik S, Naqvi SAA, Shadali AH, Khan H, Christof M, Niu C, Schwartz DA, Adler DG. Fecal Microbiota Transplantation (FMT) and Clinical Outcomes Among Inflammatory Bowel Disease (IBD) Patients: An Umbrella Review. Dig Dis Sci. 2025 May; 70(5):1873-1896.
-
Ahmad H, Click B, Morris HL, Crawford JM, Choi J, Long MD. Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World: Results From TARGET-IBD. J Clin Gastroenterol. 2025 Mar 01; 59(3):245-250.
-
Mitchel EB, Dolinger MT, Constant B, Wang Z, Guisado D, Gao M, Fusillo S, Baldassano RN, Kelsen J, Dubinsky M, Huang J, Albenberg L. Ustekinumab is safe and effective in pediatric patients with Crohn's disease. J Pediatr Gastroenterol Nutr. 2025 Apr; 80(4):653-663.
-
Hamada Y, Thomas D, Harvey ES, Stevens S, Fricker M, Lewthwaite H, McDonald VM, Gillman A, Hew M, Kritikos V, Upham JW, Gibson PG. Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma. Eur Respir J. 2025 Jan; 65(1).
-
Frisch A, Ganzel C, Ofran Y, Krayem B, Haran A, Vainstein V, Aumann S, Even-Zohar NG, Nachmias B. Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission. Eur J Haematol. 2025 Apr; 114(4):641-649.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|